SCHEMBL309466

SCHEMBL309466

CC(O)[C@@H](O)[C@@H](O)[C@H](O)CO

nearest known ligand 0.69

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.69
L3MBTL1 Q9Y468 1/20 0.69
TDP1 Q9NUW8 2/20 0.65
KDM4E B2RXH2 2/20 0.52
PDE4A P27815 1/20 0.46
USP2 O75604 1/20 0.42
SLCO1B1 Q9Y6L6 1/20 0.42
TSHR P16473 1/20 0.39
TOP1 P11387 1/20 0.36
ALDH1A1 P00352 2/20 0.33
MAPT P10636 1/20 0.33
MGAM O43451 1/20 0.31
SI P14410 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3391749 1.00 LMNA (0.69) LMNAL3MBTL1TDP1KDM4EPDE4A
SCHEMBL193773 1.00 LMNA (0.69) LMNAL3MBTL1TDP1KDM4EPDE4A
SCHEMBL13134752 1.00 LMNA (0.69) LMNAL3MBTL1TDP1KDM4EPDE4A
SCHEMBL3392184 1.00 LMNA (0.69) LMNAL3MBTL1TDP1KDM4EPDE4A
SCHEMBL15459817 1.00 LMNA (0.69) LMNAL3MBTL1TDP1KDM4EPDE4A
SCHEMBL600061 1.00 LMNA (0.69) LMNAL3MBTL1TDP1KDM4EPDE4A
SCHEMBL1017001 1.00 LMNA (0.69) LMNAL3MBTL1TDP1KDM4EPDE4A
SCHEMBL2065096 1.00 LMNA (0.69) LMNAL3MBTL1TDP1KDM4EPDE4A
SCHEMBL22128527 1.00 LMNA (0.69) LMNAL3MBTL1TDP1KDM4EPDE4A
SCHEMBL307897 1.00 LMNA (0.69) LMNAL3MBTL1TDP1KDM4EPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011084703-A2 ENZYME ASSAYS ON A DROPLET ACTUATOR ADVANCED LIQUID LOGIC, INC. (US) 2011-07-14 WO claimed
US-10624939-B2 Natural product compositions for treating or managing symptoms of ADD, ADHD, anxiety, and depression KLELE LUKE (US) 2020-04-21 US disclosed
US-20180339008-A1 NATURAL PRODUCT COMPOSITIONS FOR TREATING OR MANAGING SYMPTOMS OF ADD, ADHD, ANXIETY, AND DEPRESSION KLELE LUKE (US) 2018-11-29 US disclosed
WO-2017188662-A1 COLOR CHANGING COSMETIC COMPOSITION FOR MAKE-UP FUSED WITH ANTIOXIDANT ABILITY BIOGENICS INC. (KR) 2017-11-02 WO disclosed
US-8093062-B2 Enzymatic assays using umbelliferone substrates with cyclodextrins in droplets in oil NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-01-10 US disclosed
WO-2011095293-A1 MANUFACTURE OF EPOXYETHYL ETHERS OR GLYCIDYL ETHERS MOMENTIVE SPECIALTY CHEMICALS RESEARCH S.A. (BE) 2011-08-11 WO disclosed
WO-2011084703-A2 ENZYME ASSAYS ON A DROPLET ACTUATOR ADVANCED LIQUID LOGIC, INC. (US) 2011-07-14 WO disclosed
US-20110118132-A1 Enzymatic Assays Using Umbelliferone Substrates with Cyclodextrins in Droplets of Oil ADVANCED LIQUID LOGIC, INC. (US) 2011-05-19 US disclosed